Abstract

Background. Sex hormone intake in blood donors may affect the quality of red blood cell (RBC) products via modulation of RBC function and predisposition to haemolysis during cold storage. The aims of this study were to evaluate the association between female sex hormone intake and RBC storage outcomes, and to examine possible mechanisms by which sex hormones interact with RBCs.
Materials and methods. Sex hormone intake by race/ethnicity and menopausal status, and association analyses between hormone intake and donor scores of storage, osmotic or oxidative haemolysis, were evaluated in 6,636 female donors who participated in the National Heart, Lung and Blood Institute's RBC-Omics study. A calcium fluorophore, Fluo-3AM, was used to define RBC calcium influx in response to exogenous sex hormones or transient receptor potential cation (TRPC) channel drugs.
Results. Sex hormone intake was more prevalent in premenopausal women from all racial groups (18-31%) than in postmenopausal women (4-8%). Hormone intake was significantly (p<0.0001) associated with reduced storage haemolysis in all females, reduced osmotic haemolysis in postmenopausal donors (23.1±10.2% vs 26.8±12.0% in controls, p<0.001), and enhanced susceptibility to oxidative haemolysis in premenopausal women. In vitro, supraphysiological levels of progesterone (10 mmol/L), but not 17β-oestradiol or testosterone, inhibited calcium influx into RBC and was associated with lower spontaneous haemolysis after 30 days of cold storage (0.95±0.18% vs 1.85±0.35% in controls, p<0.0001) or in response to a TRPC6 activator.
Conclusions. Sex hormone intake in female donors is associated with changes in RBC predisposition to haemolysis. Menstrual status and the type of hormone preparation may contribute to differences in haemolytic responses of female RBCs to osmotic and oxidative stress. Progesterone modulates calcium influx into RBC via a mechanism that may involve interactions with membrane TRPC6 channels.

Downloads

Additional Files

Authors

Fang Fang - Division of Biostatistics and Epidemiology, RTI International, Durham, NC, United States of America

Kelsey Hazegh - Vitalant Research Institute, Denver, CO, United States of America

Derek Sinchar - Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA, United States of America

Yuelong Guo - Division of Biostatistics and Epidemiology, RTI International, Durham, NC, United States of America

Grier P. Page - Division of Biostatistics and Epidemiology, RTI International, Atlanta, GA, United States of America

Alan E. Mast - Versiti Blood Research Institute and Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, United States of America

Steve Kleinman - University of British Columbia, Victoria, BC, Canada

Michael P. Busch - Vitalant Research Institute, San Francisco and Department of Laboratory Medicine, University of California, San Francisco, CA, United States of America

Tamir Kanias - Vitalant Research Institute, Denver, CO, United States of America

  • Abstract viewed - 168 times
  • PDF downloaded - 85 times